Pharm prime vendor fleet
Ended Awarded Last action
- Contract number
- SPE2DU26F0K83
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,498
Award facts
- Contract value 100% obligated
- $10,498.08 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $10,498.08 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. This delivery order, issued on December 22, 2025, falls under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract (SPE2DR) established through the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, which carries a $499.9 billion ceiling value and extends through December 31, 2036. The delivery order represents one of numerous pharmaceutical supply orders issued to the contractor to support Department of Defense healthcare operations. No set-aside designation was applied to this award, demonstrating DMS Pharmaceutical Group's competitive capability in unrestricted federal procurement.
As a regional prime vendor contractor within the broader $30.3 billion PPV-G GEN V acquisition strategy, DMS Pharmaceutical Group supplies a comprehensive range of pharmaceutical products including branded and generic prescription medications, over-the-counter drugs, biologics, vaccines, and medical consumables to military healthcare facilities worldwide. The company's product portfolio encompasses specialty pharmaceuticals, oncology treatments, immunosuppressants, emergency medications, and routine pharmaceuticals, positioning it as a critical supplier within the federal military medical supply chain. With consistent contract performance demonstrated across multiple delivery orders since October 2025, DMS Pharmaceutical Group continues to fulfill the diverse pharmaceutical requirements necessary to support Department of Defense healthcare operations globally.
Quick answers
Who was awarded contract SPE2DU26F0K83?
SPE2DU26F0K83 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on December 22, 2025.
How much is contract SPE2DU26F0K83 worth?
The government has obligated $10,498 on SPE2DU26F0K83.
Is contract SPE2DU26F0K83 an order under another contract?
Yes. SPE2DU26F0K83 is a delivery order under SPE2DU25D9803, an indefinite delivery contract.
Was contract SPE2DU26F0K83 competed?
The extent of competition for SPE2DU26F0K83 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award